RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in RAPT Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
RAPT is no longer listed, and 13F filings after Q4 2025 list far fewer holders. See Q4 2025
- Institutional holders
- 0
- −105 vs. Q4 2025
- Shares held
- 0
- −29.1M (−100.0%) vs. Q4 2025
- Total value
- $0
- −$981.7M (−100.0%) vs. Q4 2025
- New holders
- 0
- 0 more added
- Sold out
- 105
- 0 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 106 | $1.02B |
| Q3 2025 | 65 | $428.0M |
| Q2 2025 | 50 | $135.6M |
| Q1 2025 | 92 | $160.0M |
| Q4 2024 | 91 | $199.5M |
| Q3 2024 | 94 | $59.9M |
| Q2 2024 | 103 | $97.0M |
| Q1 2024 | 122 | $287.2M |
| Q4 2023 | 109 | $869.3M |
| Q3 2023 | 96 | $577.8M |
| Q2 2023 | 98 | $636.7M |
| Q1 2023 | 106 | $610.5M |
| Q4 2022 | 95 | $634.7M |
| Q3 2022 | 98 | $721.0M |
| Q2 2022 | 85 | $542.7M |
| Q1 2022 | 85 | $616.1M |
| Q4 2021 | 99 | $1.02B |
| Q3 2021 | 106 | $817.8M |
| Q2 2021 | 109 | $846.6M |
| Q1 2021 | 78 | $468.4M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |